BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11102561)

  • 21. Cyclooxygenase-2 selective inhibitors and the kidney.
    Breyer MD; Hao C; Qi Z
    Curr Opin Crit Care; 2001 Dec; 7(6):393-400. PubMed ID: 11805541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat.
    Blume C; Heise G; Mühlfeld A; Bach D; Schrör K; Gerhardz CD; Grabensee B; Heering P
    Kidney Int; 1999 Nov; 56(5):1770-8. PubMed ID: 10571785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors.
    van der Bijl P; van der Bijl P
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):17-22. PubMed ID: 14552700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Non-steroidal antiinflammatory drug--management of gastrointestinal complications and inhibition of COX-2].
    Tada Y; Nagasawa K
    Nihon Rinsho; 1999 Feb; 57(2):419-24. PubMed ID: 10078017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution.
    Noroian G; Clive D
    Drug Saf; 2002; 25(3):165-72. PubMed ID: 11945113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediation of inflammation by cyclooxygenase-2.
    Seibert K; Masferrer J; Zhang Y; Gregory S; Olson G; Hauser S; Leahy K; Perkins W; Isakson P
    Agents Actions Suppl; 1995; 46():41-50. PubMed ID: 7610990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies to safely interfere with prostanoid activity while avoiding adverse renal effects: could COX-2 and COX-LOX dual inhibition be the answer?
    Gambaro G
    Nephrol Dial Transplant; 2002 Jul; 17(7):1159-62. PubMed ID: 12105234
    [No Abstract]   [Full Text] [Related]  

  • 28. The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors.
    Buttar NS; Wang KK
    Mayo Clin Proc; 2000 Oct; 75(10):1027-38. PubMed ID: 11040851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclooxygenase-2 inhibitors: promise or peril?
    Mengle-Gaw LJ; Schwartz BD
    Mediators Inflamm; 2002 Oct; 11(5):275-86. PubMed ID: 12467519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS
    Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of cyclooxygenase-2 inhibition in the kidney.
    Khan KN; Paulson SK; Verburg KM; Lefkowith JB; Maziasz TJ
    Kidney Int; 2002 Apr; 61(4):1210-9. PubMed ID: 11918727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenases, the kidney, and hypertension.
    Cheng HF; Harris RC
    Hypertension; 2004 Mar; 43(3):525-30. PubMed ID: 14732722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclooxygenase-2: a therapeutic target.
    Turini ME; DuBois RN
    Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical application of cyclooxygenase-2 inhibitors].
    Dzielska-Olczak M; Olczak S
    Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors.
    Komers R; Anderson S; Epstein M
    Am J Kidney Dis; 2001 Dec; 38(6):1145-57. PubMed ID: 11728945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New NSAIDS: COX-1, COX-2, what about them?].
    Peretz A
    Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Renal tolerance of selective inhibitors of cyclooxygenase type 2].
    Deray G
    Presse Med; 2001 Oct; 30(30):1507-12. PubMed ID: 11712212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2-specific inhibitors.
    Whelton A
    Am J Med; 2001 Feb; 110 Suppl 3A():33S-42S. PubMed ID: 11173048
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of COX-2 in acute pain and the use of selective COX-2 inhibitors for acute pain relief.
    Lee Y; Rodriguez C; Dionne RA
    Curr Pharm Des; 2005; 11(14):1737-55. PubMed ID: 15892672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.
    Qi Z; Hao CM; Langenbach RI; Breyer RM; Redha R; Morrow JD; Breyer MD
    J Clin Invest; 2002 Jul; 110(1):61-9. PubMed ID: 12093889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.